PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-2122

  1. 9,904 Posts.
    lightbulb Created with Sketch. 1285
    "Kinda looks like we've tailored our design to fit right into the OARSI recommendations....."

    Such clear messaging would be constructive in PAR's next investor slide pack and help bring all shareholders on their journey
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.